Abstract
BackgroundTumor mutational burden (TMB), defined as the number of somatic mutations per megabase of interrogated genomic sequence, demonstrates predictive biomarker potential for the identification of patients with cancer most likely...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have